Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis

  • STATUS
    Not Recruiting
  • End date
    Jul 12, 2024
  • participants needed
    740
  • sponsor
    Shire
Updated on 20 June 2021
remission
methotrexate
endoscopy
immunosuppressive agents
flexible sigmoidoscopy
tumor necrosis factor
mercaptopurine
azathioprine
tumor necrosis factor alpha
tumour necrosis
proctitis
mesalamine
hematochezia
5-aminosalicylate
sigmoidoscopy or colonoscopy

Summary

The purpose of this study is to evaluate the efficacy of SHP647 in inducing remission, based on composite score of participant-reported symptoms and centrally read endoscopy, in participants with moderate to severe ulcerative colitis (UC).

Details
Condition Ulcerative Colitis, Ulcerative Colitis (Pediatric)
Treatment Placebo, SHP647, Ontamalimab
Clinical Study IdentifierNCT03259334
SponsorShire
Last Modified on20 June 2021

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note